Ground Truths ⢠11197 implied HN points ⢠14 Dec 25
- Two main cure strategies are emerging: a "hard reset" with engineered immune cells (CARāT/CARāNK) that deplete diseaseācausing B cells and is moving toward offātheāshelf, inābody delivery for oneāshot remissions.
- A "soft reset" uses inverse or tolerogenic vaccines and Treg/dendriticācell approaches to retrain the immune system to tolerate selfāantigens instead of attacking them.
- Advances in cancer immunotherapy (CARāT, checkpoint modulation, ināvivo delivery, gene editing) are accelerating autoimmune cures, but challenges remain with cost, safety (e.g., cytokine release, neurotoxicity, vector risks) and equitable access.